Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-042176

Chief Operating Officer sold 100,000 shares

  • Chief Operating Officer acquired 100,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kling Douglas F Chief Operating Officer 2025-03-17 Option exercise 10b5-1 +88,112 132,112 D
Kling Douglas F Chief Operating Officer 2025-03-17 Option exercise 10b5-1 +11,888 $10.00 $118,880 144,000 D
Kling Douglas F Chief Operating Officer 2025-03-17 Sale 10b5-1 −100,000 44,000 D
Derivatives
Kling Douglas F Chief Operating Officer 2025-03-17 Option exercise · Option (right to buy) 10b5-1 −88,112 47,251 D
Kling Douglas F Chief Operating Officer 2025-03-17 Option exercise · Option (right to buy) 10b5-1 −11,888 650,930 D
Open-market sales · 100,000 sh
Loading xslF345X05/ownership.xml…